4-[2-(2-Azidoethoxy)ethoxy]benzenesulfonic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-[2-(2-Azidoethoxy)ethoxy]benzenesulfonic acid
• 英文别名: 4-[2-(2-azidoethoxy)ethoxy]benzenesulfonic acid
• 化学式: C10H13N3O5S
• 分子量: 287.29
• InChiKey: GUZKSPUSAABZQN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  19
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  95.6
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs
  申请人：Drug Innovation & Design, Inc.

  公开号：US20030138432A1

  公开（公告）日：2003-07-24

  The present invention relates to the compositions, methods, and applications of a novel approach to selective cellular targeting. The purpose of this invention is to enable the selective delivery and/or selective activation of effector molecules to target cells for diagnostic or therapeutic purposes. The present invention relates to multi-functional prodrugs or targeting vehicles wherein each functionality is capable of enhancing targeting selectivity, affinity, intracellular transport, activation or detoxification. The present invention also relates to ultra-low dose, multiple target, multiple drug chemotherapy and targeted immunotherapy for cancer treatment.

  本发明涉及一种新的选择性细胞靶向的组合物、方法和应用。本发明的目的是为了实现对目标细胞的选择性输送和/或选择性激活效应分子，以进行诊断或治疗。本发明涉及多功能前药或靶向载体，其中每个功能都能增强靶向选择性、亲和力、细胞内转运、激活或解毒。本发明还涉及超低剂量、多靶点、多药物化疗和靶向免疫疗法，用于癌症治疗。
• SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES
  申请人：Drug Innovation & Design, Inc.

  公开号：EP1255567A1

  公开（公告）日：2002-11-13
• [EN] SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES<br/>[FR] CIBLAGE CELLULAIRE SELECTIF: VECTEURS D'ADMINISTRATION MULTIFONCTIONNELS
  申请人：DRUG INNOVATION & DESIGN INC

  公开号：WO2001036003A2

  公开（公告）日：2001-05-25

  The present invention relates to the compositions, methods, and applications of a novel approach to selective cellular targeting. The purpose of this invention is to enable the selective delivery and/or selective activation of effector molecules to target cells for diagnostic or therapeutic purposes. The present invention relates to multi-functional prodrugs or targeting vehicles wherein each functionality is capable of enhancing targeting selectivity, affinity, intracellular transport, activation or detoxification. The present invention also relates to ultralow dose, multiple target, multiple drug chemotherapy and targeted immunotherapy for cancer treatment.